NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO,
The Board of Directors of
Summary
- Each existing share in the Company held on the record date
26 January 2022 entitles to one (1) subscription right. One (1) subscription right entitles to subscription of one (1) new share, i.e., a subscription ratio of 1:1. - The subscription price is
SEK 0.75 per new share, which, assuming the Rights Issue is fully subscribed, results in the Company receiving issue proceeds of approximately SEKm 86 before deduction of transaction costs. - The subscription rights are traded on Nasdaq First North Growth Market from and including
January 31 2022 up to and including throughFebruary 9 2022 . - The subscription period runs from and including
31 January 2022 up to and including14 February 2022 . - The Company has received subscription commitments and has entered into agreements on guarantee commitments of approximately SEKm 86, which secures the Rights issue up to 100 percent.
For complete information on the terms and conditions of the Rights Issue, please see the published Prospectus.
Prospectus
The Prospectus has been prepared in connection with the forthcoming Rights Issue and has today, on
Timetable for the Rights Issue
Record date | |
31 January – | Trading in subscription rights |
31 January – | Subscription period |
Trading in paid subscription shares (Sw. “BTA”) | |
Around | Estimated publication of outcome in the Rights Issue |
Advisers
For further information, please contact:
Phone: +46 (0)18 50 30 20
Email: anders.hultman@arocell.com
This information was submitted for publication, through the agency of the contact person set out above, at
IMPORTANT INFORMATION
The information in this press release does not constitute an offer to acquire, subscribe or otherwise trade in shares, subscription rights or other securities in
Neither subscription rights, paid subscribed shares (“BTA”) nor newly issued shares have been recommended or approved by any US federal or state securities authority or regulatory authority. No subscription rights, BTAs or newly issued shares have been registered or will be registered under the United States Securities Act of 1933 in its current wording, or under any other applicable law in
This announcement may include forward-looking statements, which are based on AroCell’s current expectations and projections about future events and financial and operational development. Words such as “intends”, “will”, “expects”, “anticipates”, “may”, “plans”, “estimates”, and other expressions that imply indications or predictions of future developments or trends, constitute forward-looking information. Forward-looking information is inherently associated with both known and unknown risks and uncertainties as it depends on future events and circumstances. Forward-looking information does not constitute a guarantee of future performance or development and actual results may differ materially from what is expressed in forward-looking information.
This information, the opinions, and forward-looking statements contained in this announcement are applied only at this date and are subject to change without notice.
This English announcement is an unofficial translation of the original Swedish announcement. In case of any discrepancies between the Swedish announcement and the English translation, the Swedish announcement shall prevail.
© Modular Finance, source